130 related articles for article (PubMed ID: 12974517)
1. Oral lichen planus and intake of drugs metabolized by polymorphic cytochrome P450 enzymes.
Kragelund C; Thomsen CE; Bardow A; Pedersen AM; Nauntofte B; Reibel J; Torpet LA
Oral Dis; 2003 Jul; 9(4):177-87. PubMed ID: 12974517
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic drug metabolizing CYP-enzymes--a pathogenic factor in oral lichen planus?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Broesen K; Pedersen AM; Smidt D; Eiberg H; Torpet LA
J Oral Pathol Med; 2009 Jan; 38(1):63-71. PubMed ID: 19192051
[TBL] [Abstract][Full Text] [Related]
3. Can the genotype or phenotype of two polymorphic drug metabolising cytochrome P450-enzymes identify oral lichenoid drug eruptions?
Kragelund C; Hansen C; Reibel J; Nauntofte B; Brosen K; Jensen SB; Torpet LA
J Oral Pathol Med; 2010 Jul; 39(6):497-505. PubMed ID: 20492431
[TBL] [Abstract][Full Text] [Related]
4. Analysis of a possible association between oral lichen planus and drug intake. A controlled study.
Hirota SK; Moreno RA; dos Santos CH; Seo J; Migliari DA
Med Oral Patol Oral Cir Bucal; 2011 Sep; 16(6):e750-6. PubMed ID: 21196843
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 2D6 polymorphism and drug utilization in patients with oral lichen planus.
Paulusová V; Rösch C; Drízhal I; Perlík F; Masín V; Sukumar S; Slezák R; Slanar O
Acta Odontol Scand; 2010 Jul; 68(4):193-8. PubMed ID: 20201714
[TBL] [Abstract][Full Text] [Related]
6. Medication use and medical history of 155 patients with oral lichenoid lesions: a retrospective study.
Alqahtani M; Woods TR; Smith MH; Bhattacharyya I; Cohen DM; Islam MN; Fitzpatrick SG
Gen Dent; 2018; 66(2):40-45. PubMed ID: 29513234
[TBL] [Abstract][Full Text] [Related]
7. Use of systemic medication in patients with oral lichen planus - a possible association with hypothyroidism.
Robledo-Sierra J; Mattsson U; Jontell M
Oral Dis; 2013 Apr; 19(3):313-9. PubMed ID: 22943671
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of prolidase activity and oxidative stress in patients with oral lichen planus and oral lichenoid contact reactions.
Batu Ş; Ofluoğlu D; Ergun S; Warnakulasuriya S; Uslu E; Güven Y; Tanyeri H
J Oral Pathol Med; 2016 Apr; 45(4):281-8. PubMed ID: 26661727
[TBL] [Abstract][Full Text] [Related]
9. Unstimulated whole salivary flow rate and anxiolytics intake are independently associated with oral Candida infection in patients with oral lichen planus.
Bokor-Bratic M; Cankovic M; Dragnic N
Eur J Oral Sci; 2013 Oct; 121(5):427-33. PubMed ID: 24028590
[TBL] [Abstract][Full Text] [Related]
10. The significance of oral and systemic factors in Australian and Croatian patients with oral lichen planus.
Vučićević Boras V; Savage NW; Brailo V; Škrinjar I; Valter K; Alajbeg I; Dulčić N; Vidović Juras D
Acta Dermatovenerol Croat; 2014; 22(2):97-102. PubMed ID: 25102794
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of micronuclear frequencies in both circulating lymphocytes and buccal epithelial cells of patients with oral lichen planus and oral lichenoid contact reactions.
Saruhanoğlu A; Ergun S; Kaya M; Warnakulasuriya S; Erbağcı M; Öztürk Ş; Deniz E; Özel S; Çefle K; Palanduz Ş; Tanyeri H
Oral Dis; 2014 Jul; 20(5):521-7. PubMed ID: 24033885
[TBL] [Abstract][Full Text] [Related]
12. Filaggrin gene mutations and the distribution of filaggrin in oral mucosa of patients with oral lichen planus and healthy controls.
Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
J Eur Acad Dermatol Venereol; 2017 May; 31(5):887-893. PubMed ID: 28000306
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and Oral Lichen Planus: Evaluation of their Correlation and Risk Factors in a Longitudinal Clinical Study.
De Carli JP; Linden MS; da Silva SO; Trentin MS; Matos Fde S; Paranhos LR
J Contemp Dent Pract; 2016 Jan; 17(1):27-31. PubMed ID: 27084859
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of oral lichen planus associated with hepatitis C virus infection, oral lichenoid contact sensitivity reaction and idiopathic oral lichen planus.
Mega H; Jiang WW; Takagi M
Oral Dis; 2001 Sep; 7(5):296-305. PubMed ID: 12117205
[TBL] [Abstract][Full Text] [Related]
15. Direct Immunofluorescence as a Helpful Tool for the Differential Diagnosis of Oral Lichen Planus and Oral Lichenoid Lesions.
Yamanaka Y; Yamashita M; Innocentini LMA; Macedo LD; Chahud F; Ribeiro-Silva A; Roselino AM; Rocha MJA; Motta AC
Am J Dermatopathol; 2018 Jul; 40(7):491-497. PubMed ID: 29293127
[TBL] [Abstract][Full Text] [Related]
16. Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis.
Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
BMC Oral Health; 2017 Jun; 17(1):103. PubMed ID: 28662707
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic oral lesions may be associated with contact allergy to substances in oral hygiene products.
Larsen KR; Johansen JD; Reibel J; Zachariae C; Pedersen AML
Clin Oral Investig; 2017 Nov; 21(8):2543-2551. PubMed ID: 28084550
[TBL] [Abstract][Full Text] [Related]
18. High percentage of oral lichen planus and lichenoid lesion in oral squamous cell carcinomas.
Ruokonen HMA; Juurikivi A; Kauppila T; Heikkinen AM; Seppänen-Kaijansinkko R
Acta Odontol Scand; 2017 Aug; 75(6):442-445. PubMed ID: 28562162
[TBL] [Abstract][Full Text] [Related]
19. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review.
Fitzpatrick SG; Hirsch SA; Gordon SC
J Am Dent Assoc; 2014 Jan; 145(1):45-56. PubMed ID: 24379329
[TBL] [Abstract][Full Text] [Related]
20. Alterations in serum lipid profile patterns in oral lichen planus: a cross-sectional study.
López-Jornet P; Camacho-Alonso F; Rodríguez-Martínes MA
Am J Clin Dermatol; 2012 Dec; 13(6):399-404. PubMed ID: 22924867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
